Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI
- 23 April 2007
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 29 (9), 1285-1295
- https://doi.org/10.1016/j.neurobiolaging.2007.03.004
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Does Donepezil Treatment Slow the Progression of Hippocampal Atrophy in Patients With Alzheimer’s Disease?American Journal of Psychiatry, 2005
- Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s DiseaseAmerican Journal of Psychiatry, 2003
- Methodological considerations for measuring rates of brain atrophyJournal of Magnetic Resonance Imaging, 2003
- MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease ☆ ☆This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health.Neurobiology of Aging, 2001
- Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's diseaseAnnals of Neurology, 1998
- Gene dose of the ε4 allele of apolipoprotein E and disease progression in sporadic late‐onset alzheimer's diseaseAnnals of Neurology, 1995
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- MR‐based hippocampal volumetry in the diagnosis of Alzheimer's diseaseNeurology, 1992
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinicianJournal of Psychiatric Research, 1975